Quantum Genomics
Created in 2006
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
2,241 2,210Activities
Technologies
Entity types
Location
Tour Maine Montparnasse, 33 Av. du Maine, 75015 Paris, France
Paris
France
Employees
Scale: 11-50
Estimated: 7
SIREN
487996647Engaged corporates
3
2 1Added in Motherbase
4 years, 8 months ago
biotech Value proposition
The objective of Quantum Genomics is to become a leading actor in the treatment of cardio-vascular diseases through the development of a new therapeutic class:
BAPAIs for BrainAminopeptidase A Inhibitors.
We wish to develop and provide effective and well tolerated therapeutic treatments for controlling high blood pressure and to for preventing related cardio-vascular risks such as heart failure.
High blood pressure remains a major public health concern.
Quantum Genomics is the only biopharmaceutical research company developing new therapies from a real breakthrough innovation based on the inhibition of brain Aminopeptidase A.
The mid-term strategic objective of the company is to sign partnership agreements with major pharmaceutical companies which will take over and bring the products from the BAPAI technology to the market.
Hypertension and Heart FailureOriginal language
The objective of Quantum Genomics is to become a leading actor in the treatment of cardio-vascular diseases through the development of a new therapeutic class:
BAPAIs for BrainAminopeptidase A Inhibitors.
We wish to develop and provide effective and well tolerated therapeutic treatments for controlling high blood pressure and to for preventing related cardio-vascular risks such as heart failure.
High blood pressure remains a major public health concern.
Quantum Genomics is the only biopharmaceutical research company developing new therapies from a real breakthrough innovation based on the inhibition of brain Aminopeptidase A.
The mid-term strategic objective of the company is to sign partnership agreements with major pharmaceutical companies which will take over and bring the products from the BAPAI technology to the market.
Quantum Genomics
Quantum Genomics est une société biopharmaceutique qui a pour mission de développer de nouvelles thérapies pour des besoins médicaux non satisfaits dans le domaine des maladies cardiovasculaires.
https://quantum-genomics.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Invest in Côte d'Azur - Team Nice Côte d'Azur Startup accelerator & VC, International Trade and Development | Invest in Côte d'Azur - Team Nice Côte d'Azur Startup accelerator & VC, International Trade and Development | Other 20 Dec 2023 | | |
 Noshaq Venture Capital and Private Equity Principals | Noshaq Venture Capital and Private Equity Principals | Other 28 Jul 2023 | | |
 BFM Business Media, Broadcast Media Production and Distribution | BFM Business Media, Broadcast Media Production and Distribution | Other 9 Sep 2022 | | |